This indicated the presence
in the blood of non-polymerized fibrin-monomers
blocked by fibrinogen degradation products. The
platelet count during the course of disease was virtually
the same with some decrease by the disease outcome
and appearance of large juvenile platelets in blood
starting with day 9.